Pharmacy Practice News: FDA Approves Exondys 51 for Duchenne Muscular Dystrophy

Katie Willmott,'s picture
September 21, 2016
Dr. Kathryn Wagner talks about the FDA approval of first drug to directly treat Duchenne Muscular Dystrophy

Dr. Kathryn Wagner, director of the Center for Genetic Muscle Disorders, talks to Pharmacy Practice News about the FDA granting approval to eteplirsen, the first drug to directly treat Duchenne muscular dystrophy, and the new approach to care for Duchenne muscular dystrophy. Click here to read the full article.

Receive Updates

Stay informed with the latest news and announcements from Kennedy Krieger.


Read inspiring stories, news and updates about the Institute's patient care, research, special education, professional training, and community programs.


Resource Finder


A free resource that provides access to information and support for individuals and families living with developmental disabilities.